CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čs. Pediat., 57, 2002, No. 6, p. 272-275
 
Treatment of Acute Idiopathic Thrombocytopenic Purpura -Comparison of Therapeutic Re- sults with Different Doses of Methylprednisolone 
Boďová I.1 ,Lukáč J.1 ,Rašková J.1 ,Smolenová J.1 ,Hostýnová E.2 ,Ponec J.3 

II.detská klinika Lekárskej fakulty Univerzity Komenského a Detskej fakultnej nemocnice s poliklinikou,Bratislava,1 prednosta prof.MUDr.L.Kovács,DrSc. Hematologicko transfuziologické oddelenie Detskej fakultnej nemocnice s poliklinikou,Bratislava,2 primárka MUDr.E.Hostýnová Oddelenie klinickej biochémie Detskej fakultnej nemocnice s poliklinikou,Bratislava,3 primárka MUDr.A.Kasanická
 


Summary:

       Idiopathic thrombocytopenic purpura (ITP)is an autoimmune disease.After sideropenic anaemia it is the second most frequent haematological disease in childhood.Its course is as a rule benign.Some patients require treatment due to the clinical signs of haemorrhage or markedly low thrombocyte values where the patient is at high risk of severe haemorrhage. In the submitted paper the authors compare the therapeutic results with methylprednisolone (MP)administe- red by the i.v.route in 26 patients hospitalized with acute ITP during a five-year period at the Second Paediatric Department,School of Medicine,Comenius University and Children ’s Hospital.The patients were divided into two groups.Patients in the first group were given MP -10 mg/kg/day i.v.for three consecutive days,patients of the second group MP -30 mg/kg/day i.v.also for three days. The objective of the work was to find out whether there are differences between the two groups as regards the rising trend of Tr,the need to proceed with treatment after the basic 3-day treatment and development of the chronic form of ITP. The authors did not observe statistically significant differences in the therapeutic results between the two groups of patients treated with different doses of methylprednisolone.

        Key words: idiopathic thrombocytopenic purpura,treatment,methylprednisolone
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER